Literature DB >> 26010909

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Stephane Kremer1, Felix Renard2, Sophie Achard2, Marco A Lana-Peixoto3, Jacqueline Palace4, Nasrin Asgari5, Eric C Klawiter6, Silvia N Tenembaum7, Brenda Banwell8, Benjamin M Greenberg9, Jeffrey L Bennett10, Michael Levy11, Pablo Villoslada12, Albert Saiz12, Kazuo Fujihara13, Koon Ho Chan14, Sven Schippling15, Friedemann Paul16, Ho Jin Kim17, Jerome de Seze18, Jens T Wuerfel16, Philippe Cabre19, Romain Marignier20, Thomas Tedder21, Danielle van Pelt22, Simon Broadley23, Tanuja Chitnis6, Dean Wingerchuk24, Lekha Pandit25, Maria Isabel Leite4, Metha Apiwattanakul26, Ingo Kleiter27, Naraporn Prayoonwiwat28, May Han29, Kerstin Hellwig30, Katja van Herle31, Gareth John32, D Craig Hooper33, Ichiro Nakashima13, Douglas Sato13, Michael R Yeaman34, Emmanuelle Waubant35, Scott Zamvil35, Olaf Stüve9, Orhan Aktas36, Terry J Smith37, Anu Jacob38, Kevin O'Connor39.   

Abstract

Brain parenchymal lesions are frequently observed on conventional magnetic resonance imaging (MRI) scans of patients with neuromyelitis optica (NMO) spectrum disorder, but the specific morphological and temporal patterns distinguishing them unequivocally from lesions caused by other disorders have not been identified. This literature review summarizes the literature on advanced quantitative imaging measures reported for patients with NMO spectrum disorder, including proton MR spectroscopy, diffusion tensor imaging, magnetization transfer imaging, quantitative MR volumetry, and ultrahigh-field strength MRI. It was undertaken to consider the advanced MRI techniques used for patients with NMO by different specialists in the field. Although quantitative measures such as proton MR spectroscopy or magnetization transfer imaging have not reproducibly revealed diffuse brain injury, preliminary data from diffusion-weighted imaging and brain tissue volumetry indicate greater white matter than gray matter degradation. These findings could be confirmed by ultrahigh-field MRI. The use of nonconventional MRI techniques may further our understanding of the pathogenic processes in NMO spectrum disorders and may help us identify the distinct radiographic features corresponding to specific phenotypic manifestations of this disease.

Entities:  

Mesh:

Year:  2015        PMID: 26010909      PMCID: PMC4828237          DOI: 10.1001/jamaneurol.2015.0248

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  56 in total

1.  Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach.

Authors:  A Pichiecchio; E Tavazzi; G Poloni; M Ponzio; F Palesi; M Pasin; L Piccolo; D Tosello; A Romani; R Bergamaschi; G Piccolo; S Bastianello
Journal:  Mult Scler       Date:  2011-12-19       Impact factor: 6.312

Review 2.  Exploring the brain network: a review on resting-state fMRI functional connectivity.

Authors:  Martijn P van den Heuvel; Hilleke E Hulshoff Pol
Journal:  Eur Neuropsychopharmacol       Date:  2010-05-14       Impact factor: 4.600

3.  Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.

Authors:  C S Yu; F C Lin; K C Li; T Z Jiang; C Z Zhu; W Qin; H Sun; P Chan
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

4.  The role of demyelination in neuromyelitis optica damage: diffusion-tensor MR imaging study.

Authors:  Fernanda C Rueda Lopes; Thomas Doring; Christianne Martins; Fernanda C Cabral; Fabíola R Malfetano; Valéria C S R Pereira; Soniza Alves-Leon; Emerson L Gasparetto
Journal:  Radiology       Date:  2012-04       Impact factor: 11.105

5.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Authors:  Sean J Pittock; Brian G Weinshenker; Claudia F Lucchinetti; Dean M Wingerchuk; John R Corboy; Vanda A Lennon
Journal:  Arch Neurol       Date:  2006-07

6.  A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations.

Authors:  Yaou Liu; Yunyun Duan; Yong He; Chunshui Yu; Jun Wang; Jing Huang; Jing Ye; Helmut Butzkueven; Kuncheng Li; Ni Shu
Journal:  Mult Scler       Date:  2011-12-19       Impact factor: 6.312

7.  Abnormal baseline brain activity in patients with neuromyelitis optica: a resting-state fMRI study.

Authors:  Yaou Liu; Peipeng Liang; Yunyun Duan; Xiuqin Jia; Fei Wang; Chunshui Yu; Wen Qin; Huiqing Dong; Jing Ye; Kuncheng Li
Journal:  Eur J Radiol       Date:  2010-06-01       Impact factor: 3.528

8.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

9.  Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica.

Authors:  Ilya Kister; Joseph Herbert; Yongxia Zhou; Yulin Ge
Journal:  Mult Scler Int       Date:  2013-01-27

10.  Venocentric Lesions: An MRI Marker of MS?

Authors:  Matthew P Quinn; Marcelo Kremenchutzky; Ravi S Menon
Journal:  Front Neurol       Date:  2013-07-22       Impact factor: 4.003

View more
  24 in total

1.  Electrodynamics and radiofrequency antenna concepts for human magnetic resonance at 23.5 T (1 GHz) and beyond.

Authors:  Lukas Winter; Thoralf Niendorf
Journal:  MAGMA       Date:  2016-04-20       Impact factor: 2.310

Review 2.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Authors:  Ruth Geraldes; Olga Ciccarelli; Frederik Barkhof; Nicola De Stefano; Christian Enzinger; Massimo Filippi; Monika Hofer; Friedemann Paul; Paolo Preziosa; Alex Rovira; Gabriele C DeLuca; Ludwig Kappos; Tarek Yousry; Franz Fazekas; Jette Frederiksen; Claudio Gasperini; Jaume Sastre-Garriga; Nikos Evangelou; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2018-03-09       Impact factor: 42.937

3.  Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Authors:  F Pache; H Zimmermann; C Finke; A Lacheta; S Papazoglou; J Kuchling; J Wuerfel; B Hamm; K Ruprecht; F Paul; A U Brandt; M Scheel
Journal:  Eur Radiol       Date:  2016-03-24       Impact factor: 5.315

4.  Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder.

Authors:  Kaspar-Josche Streitberger; Andreas Fehlner; Florence Pache; Anna Lacheta; Sebastian Papazoglou; Judith Bellmann-Strobl; Klemens Ruprecht; Alexander Brandt; Jürgen Braun; Ingolf Sack; Friedemann Paul; Jens Wuerfel
Journal:  Eur Radiol       Date:  2016-08-29       Impact factor: 5.315

Review 5.  [Optical coherence tomography in neuromyelitis optica spectrum disorders].

Authors:  F C Oertel; H Zimmermann; A U Brandt; F Paul
Journal:  Nervenarzt       Date:  2017-12       Impact factor: 1.214

Review 6.  Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.

Authors:  Joseph Kuchling; Alexander U Brandt; Friedemann Paul; Michael Scheel
Journal:  EPMA J       Date:  2017-07-25       Impact factor: 6.543

7.  MRI characteristics of Japanese macaque encephalomyelitis: Comparison to human diseases.

Authors:  Ian J Tagge; Steven G Kohama; Larry S Sherman; Dennis N Bourdette; Randall Woltjer; Paul Wang; Scott W Wong; William D Rooney
Journal:  J Neuroimaging       Date:  2021-04-30       Impact factor: 2.486

Review 8.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

9.  Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.

Authors:  Sophie Schumacher; Florence Pache; Judith Bellmann-Strobl; Janina Behrens; Petr Dusek; Lutz Harms; Klemens Ruprecht; Petra Nytrova; Sanjeev Chawla; Thoralf Niendorf; Ilya Kister; Friedemann Paul; Yulin Ge; Jens Wuerfel; Tim Sinnecker
Journal:  MAGMA       Date:  2016-04-12       Impact factor: 2.533

10.  Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.

Authors:  Lucy Matthews; Shannon Kolind; Alix Brazier; Maria Isabel Leite; Jonathan Brooks; Anthony Traboulsee; Mark Jenkinson; Heidi Johansen-Berg; Jacqueline Palace
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.